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Background: Snail1 is a transcription regulator of E-cadherin. The loss of E-cadherin seems to be a crucial step in
the process of Epithelial-mesenchymal transition (EMT). EMT initiates invasion and proliferation in many tumours.
Overexpression of Snail1 is known to be associated with poor outcome in several solid tumours. The aim of this
study was to analyse its expression profile and prognostic significance in colorectal cancer.
Methods: Tissue microarrays (TMA) containing paraffin-embedded primary colorectal cancer (CRC) tissue samples
from 251 patients were used in this study. The expression of Snail1 and E-cadherin was assessed by
immunohistochemistry in different tumour compartments, corresponding lymph node metastases and normal
colonic mucosa. Intensity of staining was classified according to the Remmele score (standardized scoring system)
as well as the semiquantitative score established by Blechschmidt et al.
Results: Snail1 expression was observed in 76% of the CRC. Loss of E-cadherin was noted in 87% of the CRC. Snail1
positive tumours were significantly correlated with Snail1 positive lymph node metastases (p=0.03). There was no
significant correlation between loss of E-cadherin and Snail1 expression, or between N-stage or grading and Snail1
expression. Kaplan-Meier survival analysis identified no prognostic impact of Snail1 expression on overall survival.
Conclusion: Snail1 expression was detectable in most of the CRC but showed no significant association with
E-cadherin loss, clinical pathological characteristics or overall survival. The observed loss of E-cadherin could be
explained by effects of other important EMT pathways, such as the Wnt-signalling cascade.
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Snail1 was the first characterized repressor of the invasion
suppressor gene CDH1, which encodes for the crucial
adhesion protein E-cadherin [1,2]. Snail1 can bind to
specific E-box regions on the CDH1 promotor, thus lead-
ing to transcriptional repression of E-cadherin. E-cadherin
is a member of a family of transmembrane glycoproteins
that mediate intercellular adhesion [3]. Loss of its
expression or function diminishes cell–cell contacts
and is known to be a key step during the process of
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reproduction in any medium, provided the ora phenotypic change in cells from epithelial to mesenchy-
mal properties. By activating this process epithelial cells
can dispose of their differentiated characteristics and
gain mesenchymal features such as invasiveness, motil-
ity and increased apoptotic resistance [4]. This revers-
ible EMT process is crucial in embryonic development
for the correct implantation of the embryo and during
gastrulation and organogenesis [5,6]. In differentiated
somatic cells this programme of EMT is normally in-
active [6]. Reactivation of this programme is known to
be a crucial event in tumour progression. During this
process, cancer cells change their phenotype from epi-
thelial to mesenchymal and gain the ability to invade
and metastasize. E-cadherin expression is frequently
downregulated in many different types of tumour, whereLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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iour of malignant cells [6,7].
Besides their involvement in EMT, Snail family mem-
bers are involved in a variety of other processes, such
as apoptosis or mesoderm formation in the developing
embryo. Snail1 has recently been shown to activate
Wnt/beta-Catenin signalling and nuclear factor kappa
B activity [8,9], and it abrogates the inhibition of the
Wnt/beta-Catenin pathway caused by the anti-tumoural
compound 1a,25-dihydroxyvitamin D3 [10]. In several
entities of human cancer, including skin [11], oral [12],
breast [13], hepatocellular [14], gastric [15] and colon
carcinomas [16], Snail1 is upregulated and frequently
associated with invasiveness, metastases and poor prog-
nosis [17,18]. The mechanism by which Snail1 influ-
ences these different cellular processes is still not totally
understood.
Snail1 RNA is not detectable in normal colon mucosa,
but is upregulated in 60–70% of colorectal adenoma and
colorectal cancers (CRC) [16,19-21]. Importantly, aber-
rant Snail1 expression in CRC was associated not only
with poor prognosis, but also with shortened relapse-
free survival [20,22]. The tumour microenvironment,
especially at the invasive front, is important for the
formation of tumour buds in CRC. At the invasive front
of CRC, the existence of tumour budding (TB: the detach-
ment and migration of small clusters of tumour cells
from the neoplastic epithelium) is correlated with a high
incidence of local invasion and distant metastasis. In a
recently published study of stage II CRC tissues, TB was
associated with increased levels of Snail1 expression as
well as a high incidence of metachronous lymph node
metastasis. Interestingly, treatment with recombinant
TGF-β1 increased the number of cells expressing CD133
and Snail1 [23].
Despite the fact that many valuable studies concerning
Snail1 expression in CRC have been published, its inci-
dence and its prognostic significance in colorectal cancer
remain undetermined.
In order to investigate the expression profile of Snail1
in CRC, we assessed its expression in formalin-fixed and
paraffin-embedded (FFPE) tissue samples of 251 patients.
We tested the association between the expression of
Snail1 and E-cadherin. Furthermore, different tumour
compartments (tumour centre and invasion front) and
histopathological as well as clinical aspects were considered.
Methods
Tissue samples and data acquisition
Paraffin-embedded tissue samples of 251 patients with
CRC were obtained from the Institute of Pathology for
immunohistochemical analysis. The specimens were
previously fixed in 10% formaldehyde, according to
established methods [24]. All tissues were verified andgraded in the pathology department. Tumour grading
was performed according to World Health Organization
(WHO) standards. The samples were randomly selected
by experienced pathologists (S.E.B) from the archives of
the Department of Pathology of the University Hospital
Duesseldorf based on the availability of follow-up data.
All patients underwent curative surgery at the University
Hospital Duesseldorf between 1996 and 2005. Patients
with neoadjuvant therapy, extended lymphatic dissem-
ination (N3), distant metastasis (M+) or incomplete
resection (R1, R2) were excluded from the cohort. Overall
survival data were retrieved from a prospectively maintained
clinical database at our hospital.
Ethics statement
The study was approved by the Ethics Committee of
the Medical Faculty of the Heinrich-Heine University
Düsseldorf.
Tissue microarrays
Fourteen tissue microarrays (TMA) were used in this
study. The TMAs contained paraffin-embedded primary
CRC tissue, lymph node metastases and normal colonic
tissue samples from archival patient specimens. Up to
six cylinders of 1.0 mm diameter (two from cancer
invasion front, two from inner tumour mass, one from
normal tissue and one from lymph node metastases, if
present) were taken from representative areas of donor
blocks of each patient and transferred to paraffin recipient
blocks, with 0.5 mm between each cylinder.
The clinicohistopathological characteristics of the colo-
rectal cancer patients, including age at diagnosis, tumour
stage, and histopathological grading, are summarized in
Table 1. The difference in sample numbers between Snail1
and E-cadherin staining (251 vs. 250) is due to loss of
one sample during staining.
Immunohistochemistry
Serial 4 μm sections of TMA blocks were prepared on a
microtome (Leica SM2000R).
For immunostaining, the slides were deparaffinised and
epitopes were retrieved using Dako Retrieval Solution
(Dako Cytomation, USA) at 95°C for 30 min, followed by
cooling to room temperature for 20 min. Endogenous
peroxidase was inactivated using 0.3% H2O2 for 30 min
at room temperature. Subsequently, the sections were
rinsed twice in phosphate buffered saline (PBS, pH 7.4)
for 5 min. Immunostaining was performed with anti-
bodies directed against E-cadherin (mouse monoclonal,
2 μg/ml) and Snail1 (rabbit polyclonal, 1 μg/ml). See
Table 2. Incubation with the primary antibodies was
performed in a moist chamber at room temperature for
30 min. The Vectastain ABC peroxidase kit was used
according to the manufacturer’s instructions (Vector
Table 1 Characteristics of the TMA collective
Patients Snail positive E-Cadherin
positive
Tissue:
Tumor 251 76% 61%
Lymphnode 47 70% 48%
Tumorstage:
T 1 8/251 (3%) 75% 50%
2 64/251 (26%) 84% 67%
3 153/251 (61%) 74% 60%
4 26/251 (10%) 69% 58%
N 0 146/251 (58%) 80% 64%
1 64/251 (26%) 70% 59%
2 41/251 (16%) 76% 54%
M 0 251/251 (100%) 76% 61%
1 0/251 (0%) 0% 0%
G 1 2/251 (1%) 100% 50%
2 209/251 (83%) 75% 64%
3 40/251 (16%) 83% 50%
Sex:
female 103/251 (41%) 75% 52%
male 148/251 (59%) 77% 67%
Age at diagnosis:
≤ 65 y 80/251 (32%) 78% 60%
> 65 y 171/251 (68%) 75% 62%
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trols using MOPC-21 (mouse IgG1, 2 μg/ml) and X0903
(rabbit immunoglobulin fraction, 1 μg/ml) were carried
out on serial sections of each sample. Diaminobenzidine
(Liquid DAB, Dako Cytomation, USA) was used to
stain the bound immunocomplex. All specimens were
counterstained with haematoxylin and eosin. A semi-
quantitative evaluation was performed by two inde-
pendent researchers using a Zeiss Axioskope.Evaluation of immunostaining
The sections were examined by two independent re-
searchers. Tissue samples from spleen and placenta em-
bedded in the TMA were used as an internal control of
staining efficiency and evaluation. ImmunohistochemicalTable 2 Concentration and supplier of the antibodies
Antibody Concentration Supplier
E cadherin (NCH-38) 2 μg/ml DAKO
Snail1 (Ab17732) 1 μg/ml AbCam
Mouse lgG1 (MOPC-21) 2 μg/ml Sigma
Rabbit-lgG (X0903) 1 μg/ml DAKOresults were evaluated for nuclear (Snail1) and membrane
(E-cadherin) -specific staining only.
For E-cadherin and Snail1 an immunoreactive score
(IRS) was set up, following Remmele et al. [25]. The
level of staining intensity (SI) was subdivided into
four groups: 0 (negative), 1 (weak), 2 (moderate) and
3 (strong). The percentage of positive cells (PP) was
regarded as 0 (none), 1 (≤10%), 2 (11–50%), 3 (51–80%)
and 4 (>80% positive tumour cells). The product of SI
and PP is the IRS (0–12). A score of 0–2 was regarded
as negative, 3–12 as positive [25].
To compare the E-cadherin staining to the normal mu-
cosa, we also used the semiquantitative score established
by Blechschmidt et al. for the same purpose [26]. The
level of staining intensity was again subdivided into
groups ranging from 0–3. Tumours with less than 20%
of E-cadherin positive cells in category 3 were regarded
as downregulated compared to normal colonic mucosa.
Statistical analysis
Statistical analysis was performed using the SPSS
software (Version 18). The threshold for statistical
significance was p<0.05. To compare two independent,
non-parametric samples we used the Mann–Whitney-U
test. All survival analyses were performed using the
Kaplan-Meier method. The significance of differences
between groups was assessed using the log rank test.
The Cox-Regression analysis was used to evaluate the
risk of differences between groups in the Kaplan-Meier
survival analyses (hazard ratio).
In all boxplots, the boxed area corresponds to the
25th to 75th percentile. The horizontal bars indicate
the median. The whiskers show the 5th to 95th per-
centile. All outliers are indicated as dots.
Results
Snail1 expression and its association with E-cadherin in
colorectal cancer
We detected Snail1 in 76% (191/251) of the 251 samples,
while E-cadherin expression was lacking in 39% (97/250)
(Remmele score, Figure 1). In 87% (217/250), E-cadherin
expression was downregulated compared to normal mu-
cosa (Blechschmidt score [26]). We did not detect any
correlation in the whole tumour between the expression
of Snail1 and loss (Remmele score) (p=0.85) or even
downregulation (Blechschmidt score) (p=0.82) of E-
cadherin (Figures 2, 3). We detected no significant
difference in the distribution of E-cadherin in the dif-
ferent tumour compartments (tumour centre, invasion
front) and expression of Snail1 in the same compartment.
However, Snail1 positive tumours were significantly
correlated with Snail1 positive lymph node metastases
(p=0.03); but in those there was again no significant cor-
relation between Snail1 and loss of E-cadherin (p=0.53).
Figure 1 Snail1 and E-cadherin staining. Upper left: tumor center; upper right: invasion front; lower left: lymph node metastasis; lower right:
normal colonic mucosa. Top row of each sample: positive staining (100x); middle row: detail of boxed area (400x), arrow points to positive
nuclear (Snail1) or membranous (E-cadherin) staining; lower row: negative control of same area (400x). Scale = 100μm.
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Small tumours (T1+T2) showed a trend towards higher
Snail1 expression, compared to advanced tumours
(T3+T4) (p=0.077, Figure 4A). Although this correl-
ation did not reach significance, when considering the
separate compartments, we observed significantly higher
expression of Snail1 in the tumour centre of small
tumours (p=0.048, Figure 4B). Snail1 expression at the
invasion front did not differ significantly between small
and advanced tumours (p=0.066, Figure 4C).
Likewise, there was no difference in Snail1 expression
between the different N-stages or between low-grade
(G1+G2) and high-grade (G3+G4) cancer (p=0.42;
p=0.17, respectively).E-cadherin and TNM
There was a significant difference in E-cadherin expression
between low-grade (G1+G2) and high-grade (G3+G4)
CRC. The high-grade tumours showed significantly
reduced E-cadherin expression (p=0.03, Figure 5).
In terms of T-stage, there was no correlation between
E-cadherin and small or advanced tumours (p=0.17).
Influence on overall survival
Age at diagnosis, lymph node-metastasis (N), tumour
stage (T) and grading (G) showed a significant influence
on overall survival (Figure 6), while neither Snail1 nor
E-cadherin expression seemed to have any effect (Figure 7).
Cox-regression analysis of overall survival showed a hazard
Figure 2 E-cadherin staining according to the Remmele score
(y-axis) of Snail1 positive and negative tumors (x-axis).
Figure 3 Snail1 staining according to the Remmele score (y-axis)
of E-cadherin reduced or normal tumors (x-axis, Blechschmidt
score: E-cadherin lost or normal compared to normal
colonic mucosa).
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and 3.3 for age at diagnosis (p<0.0001, p=0.045, p<0.0001,
respectively). There was no significant correlation between
T-stage or sex and overall survival (p=0.1, p=1.0, respect-
ively, Table 3).
Effect of Snail1 and E-cadherin on UICC stage and tumour
location
We found a significant correlation between UICC stage
and tumour location (p=0.01). Tumours with a high
UICC stage tended to be located in the right colon,
while carcinomas of the left colon showed a lower UICC
stage. The UICC stage showed no correlation with
either E-cadherin or Snail1 expression. We were also
unable to detect any difference in the expression of Snail1
or E-cadherin between rectal, left or right colon cancers.
Discussion
Invasion and metastasis are life-limiting aspects of
malignant tumours. It has been shown in a variety of
studies that cancer cells use EMT to downregulate their
cell–cell contacts and become motile and invasive [19].Many authors regard EMT as a major mechanism en-
abling metastasis and initiating the transition between
benign and malignant tissue.
Here, we analysed the nuclear expression of Snail1
transcriptional factor in a large cohort of human colo-
rectal carcinomas. Snail1 is one of the best-characterized
E-cadherin gene repressors required for triggering EMT.
Only cells presenting immunostaining in the nucleus
were considered Snail1-positive. The diffuse staining
detected occasionally in the cytosol in some epithelial
cells was not considered to indicate Snail1 expression,
since Snail1 is not active in this compartment [27,28].
Conflicting data have been published concerning Snail1
expression in cancer cells and non-malignant epithelium.
While Franci et al. found the protein only in carcinoma
cells [16], Bezdekova et al. and others found Snail1 expres-
sion in normal epithelium [7,29]. In a previous study with
a much smaller cohort (n=10), we were unable to detect
Snail1 mRNA expression in normal colonic tissue [21].
However, in this present analysis Snail1 protein expression
was also sporadically detected in single cells in the normal
colonic tissue, located at the base of crypts. Colonic
Figure 4 A-C: Different Snail1 staining in small (T1+T2) and advanced (T3+T4) colorectal cancers. Y-axis: Snail1 Remmele score. A: overall
tumor; B: Snail1 staining in the tumor center; C: Snial1 staining in the invasion front.
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the crypt base [30]. Recently, a number of studies have
provided evidence that Snail1 is involved in the preser-
vation of stem cell function [31-34]. Whether Snail1 is
involved in stem cell functions or cell renewal in colon
epithelium are questions we can only speculate about.
Analyses of Snail1 gene expression in different types
of human tumours indicate that Snail1 is associatedFigure 5 Different E-cadherin staining in low grade (G1+G2) and
high grade (G3+G4) tumors. Y-axis: E-cadherin Remmele score.with invasion, secondary metastasis and poor prognosis
[35-37]. In our present study, Snail1 expression was
detected in 76% of the CRC, similar to previously published
expression rates in CRC tissues [13,16]. Downregulation
of E-cadherin was observed in 87% of the CRC. The
percentage of immunoreactive cells in the samples was
variable and heterogeneous for both Snail1 and E-
cadherin expression. Interestingly, a significant correl-
ation between Snail1 expression and E-cadherin loss
was not detectable. However, we detected a significant
correlation between the expression of Snail1 in the
tumour and Snail1 expression in the corresponding
lymph node metastasis.
We observed significantly elevated Snail1 expression
in the tumour centre of small (T1 and T2) compared to
advanced tumours (T3 and 4). This could be attributed
to transient Snail1 activation [6,38] in the tumour centre
of T1 and T2 tumours. There was no difference in
Snail1 expression between the T-stages at the invasion
front. Snail1 expression at the invasion front was not
elevated compared to the tumour centre. Likewise,
Snail1 expression was not correlated with histopatho-
logical characteristics, such as advanced dedifferenti-
ation (grading) or lymphatic dissemination (N-stage).
Interestingly, Franci et al. found higher Snail1 expres-
sion at the invasion front of CRC, associated with a
significant negative prognostic impact on stage II colon
tumours [16]. We noticed a trend between Snail1 expres-
sion at the invasion front and loss of E-cadherin in
the corresponding lymph node metastasis. Further-
more, Snail1 positive tumours were significantly corre-
lated with Snail1 positive lymph node metastases.
The expression of Snail1 in CRC shows variation in
the literature. There is evidence that cells from different
tumour compartments interact and thus influence the
expression of different oncoproteins. This might explain
the observed difference in Snail1 expression between the
Figure 6 Kaplan-Meier graphs showing the overall survival for A: age at diagnosis, B: N-stage, C: T-stage and D: grading. All factors
showed a significant impact on overall survival.
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Brabletz et al. found [39] beta-catenin overexpression
at the invasion front of CRC. In contrast, cells in the
tumour centre often showed no nuclear beta-catenin
staining. They postulated that regulatory events in the
tumour itself could lead to a different distribution of
this oncoprotein. It is possible that surrounding tissue
at the invasion front can influence tumour cells, lead-
ing to nuclear translocation of beta-catenin, where it
may play a direct role in tumour invasion processes
[39]. Snail1 is postulated to activate EMT pathways
like Wnt signalling by binding to beta-catenin, thereby
establishing a positive feedback loop for Wnt-dependent
transcription [40]. Thus, Wnt signalling and Snail1-
dependent induction of EMT might be interconnected
by multiple positive loops, possibly adding to the robustnessFigure 7 Kaplan-Meier graphs showing the overall survival for A: Sna
significant impact on overall survival.of both signalling systems. There is evidence for a close
relationship between both pathways in vivo, so the loss
of E-cadherin could be attributed to the effects of
other EMT pathways, perhaps initially triggered by Snail1
activation [10,18].
Becker et al. studied the expression of Snail1 in adeno-
carcinomas of the upper gastrointestinal tract and found
no evidence of any significant association with clinical
and pathological parameters [19]. In addition, the same
authors detected an association of Snail1 expression
with tumour grade in endometrial carcinomas [41] and
with overall survival in ovarian carcinomas [42].
In our study, neither Snail1 nor E-cadherin expression
seemed to have an effect on overall survival. Since the
association between age and overall survival was very
strong in this study, the lack of data on disease-specificil1 status and B: E-cadherin status. Neither one showed any
Table 3 Cox-Regression of clinical parameters
COX-Reg stand. error P value HR
sex 0.19 0.98 1,00
age 0.25 <0.0001 3,32
T 0.18 0.12 1,32
N 0.12 <0.0001 1,74
G 0.22 0.04 1,56
Stand. error = standard error; HR = hazard ratio.
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of Snail1 on disease outcome.
Furthermore, we found no evidence of any association
of Snail1 with clinicopathological parameters (N-stage,
grading, age or sex), with the exception of the signifi-
cantly elevated Snail1 expression in the tumour centre
of small (T1 and T2) compared to advanced (T3 and
T4) tumours.
The tumour location, assessed according to the Inter-
national Classification of Diseases (ICD-10) as endorsed
by the WHO, was correlated with the expression profiles
of Snail1 and E-cadherin. However, there was no differ-
ence in Snail1 expression between rectal, left or right
colon cancers.
In conclusion, Snail1 expression was detectable in
most of the CRC. Our study indicates that Snail1 expres-
sion does not seem to be associated with clinical and
pathological data or with overall survival in CRC, even
though we cannot rule out an influence on disease-
specific survival. Further investigation to assess the rela-
tionship between Snail1 and other EMT markers and its
relevance in the progression of CRC might be beneficial.
Conclusion
Snail1 expression was detectable in most of the CRC but
showed no significant association with E-cadherin loss,
clinical pathological characteristics or overall survival. The
observed loss of E-cadherin could be explained by effects
of other important EMT pathways, such as the Wnt-
signalling cascade.
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